CH

Romain N Zufferey


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Romain N Zufferey: Innovator in Lentiviral Vector Production Systems

Introduction

Romain N Zufferey is a notable inventor based in Switzerland. He has made significant contributions to the field of gene therapy through his innovative work on lentiviral vector production systems. His research focuses on creating safe and efficient vectors for expressing transgenes, which are crucial for various genetic treatments.

Latest Patents

Romain N Zufferey holds a patent titled "Methods And Compositions Relating To Improved Lentiviral Vector Production Systems." This invention provides HIV-derived lentivectors that are multiply modified to enhance safety, efficiency, and potency for gene therapy applications. The lentiviral vectors include various combinations of an inactive central polypurine tract, a stuffer sequence that may encode drug susceptibility genes, and a mutated hairpin in the 5' leader sequence that significantly reduces replication. These elements are designed to work alongside other features of lentiviral vectors, such as a self-inactivating configuration for biosafety and various promoters, including the EF1.alpha. promoter. The vectors also incorporate additional transcription-enhancing elements, making them valuable tools for genetic treatments of inherited and acquired disorders, cancer therapies, and the study of cellular and genetic processes.

Career Highlights

Romain N Zufferey is affiliated with the Institut Clayton De La Recherche, where he continues to advance his research in gene therapy. His work has been instrumental in developing innovative solutions for complex genetic challenges.

Collaborations

Romain collaborates with Didier Trono, a fellow researcher, to further enhance the impact of their work in the field of gene therapy.

Conclusion

Romain N Zufferey's contributions to lentiviral vector production systems represent a significant advancement in gene therapy. His innovative approaches and collaborations continue to pave the way for future developments in genetic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…